Jonathan Howlett, MD FRCPC

Professor of Medicine
Canadian Heart Failure Society
University of Calgary, Canada

Novartis Canada Pharmaceuticals Inc. (Speaker/Honoraria includes speakers bureau, symposia, and expert witness)

Poster(s):

• (P103) EFFECTIVENESS, SAFETY, AND TOLERABILITY OF SACUBITRIL/VALSARTAN OVER 3 YEARS OF FOLLOW-UP IN CANADIAN PRACTICE: INSIGHTS FROM THE PARTHENON REGISTRY
  Friday, October 28, 2022

  1:30 PM – 1:40 PM EDT